Intra-Cellular Therapies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.

About ITCI

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.

CEO

Sharon L. Mates

CEOSharon L. Mates

Employees

610

Employees610

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2002

Founded2002

Employees

610

Employees610

ITCI Key Statistics

Market cap

7.63B

Market cap7.63B

Price-Earnings ratio

-50.15

Price-Earnings ratio-50.15

Dividend yield

—

Dividend yield—

Average volume

2.22M

Average volume2.22M

High today

$75.49

High today$75.49

Low today

$72.41

Low today$72.41

Open price

$73.71

Open price$73.71

Volume

725.98K

Volume725.98K

52 Week high

$84.89

52 Week high$84.89

52 Week low

$45.50

52 Week low$45.50

ITCI News

Yahoo Finance 15h

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters ... - Yahoo Finance

Intra-Cellular Therapies Inc. NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopha...

Analyst ratings

88%

of 16 ratings

Buy

87.5%

Hold

12.5%

Sell